May 20, 2020
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
May 14, 2020
Windtree Therapeutics Reports First Quarter 2020 Financial Results and Provides Key Business Updates
Apr 29, 2020
Windtree Announces First Patient Enrolled in AEROSURF® Bridging Study for the Treatment of Respiratory Distress Syndrome
Mar 31, 2020
Windtree Enters into Agreement with Lee's Pharmaceutical for Non-Dilutive Funding of the Continued Development of AEROSURF®
Mar 24, 2020
Windtree to Pursue Clinical Study of Lung Injury Treatment in COVID-19 Patients with its KL4 Surfactant Therapy
Dec 09, 2019
Windtree Therapeutics Completes $26.4 Million Private Placement
Sep 06, 2019
Windtree Therapeutics Announces Publication of Results of Lung Deposition Study of Aerosolized Lucinactant
Aug 13, 2019
Windtree Announces FDA Fast Track Designation for Istaroxime
Jun 19, 2019
Windtree Therapeutics to Host Research & Development Day in New York City on June 25
Jun 04, 2019
Windtree and Eleison Announce Initial Results of Delivering Inhaled Lipid Cisplatin (ILC) Utilizing Windtree's Drug Delivery Technology
May 20, 2019
Windtree Therapeutics Reports First Quarter 2019 Financial Results and Provides Key Business Updates
Dec 21, 2018
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company Targeting Cardiovascular and Respiratory Diseases
Dec 10, 2018
New Data from the AEROSURF® Phase 2b Clinical Program shows AEROSURF® Appears to Reduce Incidence and Severity of Bronchopulmonary Dysplasia in Preterm Infants with RDS
Jul 23, 2018
Windtree Announces Completion of New Design Development for its Aerosol Delivery System (ADS) including Successful Performance Testing
May 31, 2018
Windtree Therapeutics' Aerosolized KL4 Surfactant Preclinical Data in Influenza Presented at the 2018 American Thoracic Society Meeting
May 22, 2018
Windtree Receives $0.7 Million SBIR Grant in Continuing Support of the AEROSURF® Phase 2b Clinical Trial Completion
Apr 04, 2018
Windtree Therapeutics Announces Closing of $2.6 Million Private Placement
Dec 28, 2017
Windtree Therapeutics to Provide AEROSURF® and Business Updates
Dec 21, 2017
Windtree Therapeutics Announces Reverse Stock Split
Dec 12, 2017
Windtree Therapeutics to Participate in Corporate Access Event in San Francisco, January 8 - 10, 2018